Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Insulin like growth factor 2 receptor (IGF2R) ELISA Kit-Sandwich

Name: Canine Insulin like growth factor 2 receptor (IGF2R) ELISA Kit-Sandwich
SKU: EK10F812
Rating: 5 (1 reviews)

Cat. No.EK10F812

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Basket

Product Overview

BioVenic Canine IGF2R ELISA Kit-Sandwich is designed for the quantitative determination of Canine IGF2R in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine IGF2R.

Target Species Canine

Species Reactivity Canine

Detection Range 0.2-10 ng/mL

Sensitivity 0.03 ng/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Insulin like growth factor 2 receptor is encoded by the IGF2R gene in dogs. It sequesters the insulin-like growth factor (IGF-II) for internalization and degradation and also is considered a tumor suppressor with mutations being found in several cancers

Target/Biomarker Canine IGF2R

Target Synonym insulin like growth factor 2 receptor; cation-independent mannose-6-phosphate receptor

Gene ID 484067

UniProt ID A0A8C0TN36

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Boisclair, C. et al. Characterization of IGF2R molecular expression in canine osteosarcoma as part of a novel comparative oncology approach. International journal of molecular sciences. 2023, 24: 1867.